Nuvation Bio (NUVB) EPS (Basic) (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly EPS (Basic) of $15.54 for Q1 2026, up 109.88% year-over-year from $7.4 in Q1 2025, and up 114.5% quarter-over-quarter from -$107.14 in Q4 2025.
Powered by 
Analysis
Nuvation Bio (NUVB) EPS (Basic) (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported EPS (Basic) for 7 consecutive years, with $15.54 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 109.88% year-over-year to $15.54; the TTM figure through Mar 2026 stood at -$420.33 (up 76.53% YoY), while the FY2025 annual figure was -$599.13, up 71.65% from the prior year.
- EPS (Basic) rose to $15.54 in Q1 2026 per NUVB's latest filing, from -$107.14 in the prior quarter.
- Across five years, EPS (Basic) topped out at $15.54 in Q1 2026 and bottomed at -$1889.7 in Q2 2024.
- Historically, EPS (Basic) has averaged -$217.92 across 5 years, with a median of -$107.14 in 2025.
- Annual changes were most pronounced in 2022 — EPS (Basic) sank 82870.61% — and 2026, when it jumped 109.88%.
- Nuvation Bio's EPS (Basic) stood at -$96.18 in 2022, then surged by 34.51% to -$62.99 in 2023, then sank by 192.06% to -$183.97 in 2024, then jumped by 41.76% to -$107.14 in 2025, then soared by 114.5% to $15.54 in 2026.
- Business Quant data shows NUVB's EPS (Basic) at $15.54 in Q1 2026, -$107.14 in Q4 2025, and -$162.95 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Nuvation Bio | 2.38 Bn | 2.38 Bn | 30.78 Mn | -0.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | -0.16 |
| Jun 30, 2025 | -0.17 |
| Mar 31, 2025 | -0.16 |
| Dec 31, 2024 | -0.18 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | -1.89 |
| Mar 31, 2024 | -0.07 |
| Dec 31, 2023 | -0.06 |
| Sep 30, 2023 | -0.09 |
| Jun 30, 2023 | -0.09 |
| Mar 31, 2023 | -0.10 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | -0.12 |
| Jun 30, 2022 | -0.16 |
| Mar 31, 2022 | -0.10 |
| Dec 31, 2021 | -0.13 |
| Sep 30, 2021 | -0.11 |